Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
ContributorsRuperto, Nicolino; Brunner, Hermine I; Quartier, Pierre; Constantin, Tamás; Wulffraat, Nico; Horneff, Gerd; Brik, Riva; McCann, Liza; Kasapcopur, Ozgur; Rutkowska-Sak, Lidia; Schneider, Rayfel; Berkun, Yackov; Calvo, Inmaculada; Erguven, Muferet; Goffin, Laurence; Hofer, Michael; Kallinich, Tilmann; Oliveira, Sheila K; Uziel, Yosef; Viola, Stefania; Nistala, Kiran; Wouters, Carine; Cimaz, Rolando; Ferrandiz, Manuel A; Flato, Berit; Gamir, Maria Luz; Kone-Paut, Isabelle; Grom, Alexei; Magnusson, Bo; Ozen, Seza; Sztajnbok, Flavio; Lheritier, Karine; Abrams, Ken; Kim, Dennis; Martini, Alberto; Lovell, Daniel J
Published inThe New England journal of medicine, vol. 367, no. 25, p. 2396-2406
Publication date2012
Abstract
Keywords
- Adolescent
- Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
- Antibodies, Monoclonal/adverse effects/therapeutic use
- Arthritis, Juvenile Rheumatoid/complications/drug therapy
- Child
- Child, Preschool
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glucocorticoids/therapeutic use
- Humans
- Infection/chemically induced
- Interleukin-1beta/antagonists & inhibitors
- Kaplan-Meier Estimate
- Macrophage Activation Syndrome/etiology
- Male
- Methotrexate/therapeutic use
- Neutropenia/chemically induced
- Thrombocytopenia/chemically induced
Affiliation entities
Citation (ISO format)
RUPERTO, Nicolino et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. In: The New England journal of medicine, 2012, vol. 367, n° 25, p. 2396–2406. doi: 10.1056/NEJMoa1205099
Main files (1)
Article (Published version)
Identifiers
- PID : unige:30597
- DOI : 10.1056/NEJMoa1205099
- PMID : 23252526
Journal ISSN0028-4793
